Life Sciences

Galderma, the world’s largest independent dermatology company headquartered in Lausanne, Switzerland, announced Thursday a co-development and option-to-acquire agreement with Framingham-based medical device firm Sofregen Inc.

Hologic, a Marlborough-based medical technology company focused on women’s health, released findings from its first Hologic Global Women’s Health Index, according to a Tuesday press release.

Akoya Biosciences, a Marlborough bioscience company, has appointed Dr. Myla Lai-Goldman, who has worked extensively in diagnostics and is the chair and co-founder of GeneCentric Therapeutics Inc. of North Carolina, to its board of directors, according to a Wednesday announcement.

Rentschler Biopharma, a global contract development and manufacturing organization with offices in Germany and Milford, has named Christian Schetter as its new chief scientific officer, effective this past Wednesday, according to a Monday announcement.

Miach Orthopaedics, a Westborough bioengineering plant specializing in surgical implants, announced Monday the first patient successfully treated using the company’s Bridge-Enhanced ACL Repair implant.

Marlborough diagnostic company Immunovia, Inc. announced on Monday it has acquired a global license from the South Korean company JW BioScience’s intellectual property portfolio, granting Immunovia global commercial rights for two biomarkers.

A 33,800-square-foot office building on Otis Street in Northborough was sold for $3.15 million to Ciminelli Real Estate Corporation in Buffalo, according to the Worcester Registry of Deeds. 

The Reactory Summit, a one-day biomanufacturing conference to be held at the Beechwood Hotel, has been postponed from Oct. 13 to April 6, according to The Reactory’s website.

Marlborough company Sunovion Pharmaceuticals announced on Thursday it granted exclusive commercial license rights in Europe to Portugese company Bial for Sunovion's KYNMOBI, an under-the-tongue drug treating OFF episodes in patients with Parkinson’s disease.

Arch Therapeutics, a Framingham biotechnology company specializing in wound care and biosurgical devices, announced Thursday a partnership with Lovell Government Services, a Floridia medical supply distributor.